Skip to content

Prediction of lymph node metastasis in T1 colorectal cancer with artificial intelligence

Prediction of lymph node metastasis in T1 colorectal cancer with artificial intelligence - AMED T1 study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000038609
Enrollment
3500
Registered
2019-11-22
Start date
2017-10-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T1 colorectal cancer

Interventions

None listed

Sponsors

Showa University Nothern Yokohama Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with T1 colorectal cancer who received complete treatment for submucosal invasive colorectal cancer with endoscopic resection or surgical resection 2.Written informed consent

Exclusion criteria

Exclusion criteria: 1.Lynch syndrome 2.Familial adenomatous polyposis 3.Ulcerative colitis 4.Neo adjuvant chemo- or radio-therapy 5.Synchronous invasive carcinoma

Design outcomes

Primary

MeasureTime frame
Predictive value (sensitivity, specificity, accuracy, AUC)

Countries

Japan

Contacts

Public ContactKatsuro Ichimasa

Showa University Nothern Yokohama Hospital Digestive Disease Center

ichitommy14@yahoo.co.jp045-949-7000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026